{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:43:58Z","timestamp":1754160238142,"version":"3.41.2"},"reference-count":15,"publisher":"National Center for Global Health and Medicine (JST)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["GHM Open"],"published-print":{"date-parts":[[2025,7,1]]},"DOI":"10.35772\/ghmo.2024.01010","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T18:06:57Z","timestamp":1744308417000},"page":"43-46","source":"Crossref","is-referenced-by-count":0,"title":["Paraganglioma of the spermatic cord: A rare tumor with unique imaging findings and diagnostic challenges"],"prefix":"10.35772","volume":"5","author":[{"given":"Naoki","family":"Yamamine","sequence":"first","affiliation":[{"name":"Department of Urology, Teikyo University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Urology, Teikyo University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoe","family":"Numakura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Teikyo University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Radiology, Teikyo University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Urology, Teikyo University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuumi","family":"Tokura","sequence":"additional","affiliation":[{"name":"Department of Urology, Teikyo University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuki","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Urology, Teikyo University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketo","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Urology, Teikyo University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Sasajima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Teikyo University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Teikyo University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21485","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lenders JWM, Kerstens MN, Amar L, <i>et al.<\/i> Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: A position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens. 2020; 38:1443-1456.","DOI":"10.1097\/HJH.0000000000002438"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. N\u00f6lting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, Eisenhofer G, Grossman A, Pacak K. Personalized management of pheochromocytoma and paraganglioma. Endocr Rev. 2022; 43:199-239.","DOI":"10.1210\/endrev\/bnab019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lam AK. Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocr Pathol. 2017; 28:213-227.","DOI":"10.1007\/s12022-017-9484-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fassnacht M, Assie G, Baudin E, Eisenhofer G, de la Fouchardiere C, Haak HR, de Krijger R, Porpiglia F, Terzolo M, Berruti A; ESMO Guidelines Committee. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31:1476-1490.","DOI":"10.1016\/j.annonc.2020.08.2099"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Van Nederveen FH, Gaal J, Favier J, <i>et al.<\/i> An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: A retrospective and prospective analysis. Lancet Oncol. 2009; 10:764-771.","DOI":"10.1016\/S1470-2045(09)70164-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Thompson LD. Pheochromocytoma of the adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: A clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol. 2002; 26:551-566.","DOI":"10.1097\/00000478-200205000-00002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M; Phaeochromocytoma Study Group in Japan. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr. Relat. Cancer. 2014; 21:405-414.","DOI":"10.1530\/ERC-13-0494"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Eisenhofer G, Lenders JWM, Siegert G, Bornstein SR, Friberg P, Milosevic D, Mannelli M, Linehan WM, Adams K, Timmers HJ, Pacak K. Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer. 2012; 48:1739-1749.","DOI":"10.1016\/j.ejca.2011.07.016"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hescot S, Curras-Freixes M, Deutschbein T, <i>et al.<\/i> Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European network for the study of adrenal tumors retrospective study. J Clin Endocrinol Metab. 2019; 104:2367-2374.","DOI":"10.1210\/jc.2018-01968"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fishbein L, Leshchiner I, Walter V, <i>et al.<\/i> Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017; 31:181-193.","DOI":"10.1016\/j.ccell.2017.01.001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fishbein L, Khare S, Wubbenhorst B, DeSloover D, D&apos;Andrea K, Merrill S, Cho NW, Greenberg RA, Else T, Montone K, LiVolsi V, Fraker D, Daber R, Cohen DL, Nathanson KL. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nat Commun. 2015; 6:6140.","DOI":"10.1038\/ncomms7140"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Job S, Draskovic I, Burnichon N, <i>et al.<\/i> Telomerase activation and ATRX mutations are independent risk factors for metastatic pheochromocytoma and paraganglioma. Clin Cancer Res. 2019; 25:760-770.","DOI":"10.1158\/1078-0432.CCR-18-0139"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Purnell S, Sidana A, Maruf M, Grant C, Agarwal PK. Genitourinary paraganglioma: Demographic, pathologic, and clinical characteristics in the Surveillance, Epidemiology, and End Results database (2000-2012). Urol Oncol. 2017; 35:457.e9-457.e14.","DOI":"10.1016\/j.urolonc.2017.02.006"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hao Y, Li X, Xie J, He W, Wang C, Sun F. Rare case of a preoperatively diagnosed spermatic cord paraganglioma and literature review. Front Oncol. 2024; 14:1373727.","DOI":"10.3389\/fonc.2024.1373727"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Archier A, Varoquaux A, Garrigue P, <i>et al.<\/i> Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases. Eur J Nucl Med Mol Imaging. 2016; 43:1248-1257.","DOI":"10.1007\/s00259-015-3268-2"}],"container-title":["GHM Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ghmo\/5\/1\/5_2024.01010\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T05:00:19Z","timestamp":1753506019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ghmo\/5\/1\/5_2024.01010\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.35772\/ghmo.2024.01010","relation":{},"ISSN":["2436-293X","2436-2956"],"issn-type":[{"type":"print","value":"2436-293X"},{"type":"electronic","value":"2436-2956"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"article-number":"2024.01010"}}